糖尿病人类胰腺供者胰岛激素原转化酶1/3表达的定量分析
本研究对来自nPOD库的54例供者胰腺切片进行免疫染色和高维图像分析,评估非糖尿病、自身抗体阳性、1型糖尿病和2型糖尿病供者胰岛α、β、δ细胞中PC1/3的表达模式。结果显示1型糖尿病供者β细胞PC1/3减少而α细胞PC1/3增加,提示β细胞功能恶化及α细胞激素原加工潜在增强。
要点
- 1型糖尿病供者胰岛胰岛素阳性面积和PC1/3阳性面积均减少,PC1/3与胰岛素共定位减少。
- 1型糖尿病供者胰岛胰高血糖素阳性面积及胰高血糖素阳性/PC1/3阳性细胞百分比增加,PC1/3与胰高血糖素共定位增加。
- 近期起病1型糖尿病供者胰岛生长抑素阳性细胞面积和生长抑素染色强度升高。
核心结论
- 1型糖尿病供者胰岛β细胞PC1/3减少而α细胞PC1/3增加,揭示了β细胞功能恶化及α细胞激素原加工潜在增强。
研究设计与样本
- 横断面队列研究,对来自nPOD库的54例供者胰腺切片进行免疫染色和高维图像分析。
主要发现
- 1型糖尿病供者α和β细胞形态改变,包括α和β细胞大小减小。
- 1型糖尿病供者胰岛胰岛素阳性面积和PC1/3阳性面积均减少,PC1/3阳性及胰岛素阳性/PC1/3阳性细胞百分比降低,PC1/3与胰岛素共定位减少。
- 1型糖尿病供者胰岛胰高血糖素阳性面积、胰高血糖素阳性及胰高血糖素阳性/PC1/3阳性细胞百分比增加,PC1/3与胰高血糖素共定位增加。
- 近期起病1型糖尿病供者胰岛生长抑素阳性细胞面积和生长抑素染色强度升高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Islet prohormone-processing enzymes convert peptide hormone precursors to mature hormones. Defective beta cell prohormone processing and the release of incompletely processed peptide hormones are observed prior to the onset of diabetes, yet molecular mechanisms underlying impaired prohormone processing during the development of diabetes remains largely unknown. Previous studies have shown that prohormone convertase 1/3 (PC1/3) protein and mRNA expression levels are reduced in whole islets from donors with type 1 diabetes, although whether PC1/3-mediated prohormone processing in alpha and beta cells is disrupted in type 1 diabetes remained to be explored. Herein, we aimed to analyse the expression of PC1/3 in islets from non-diabetic donors, autoantibody-positive donors and donors diagnosed with type 1 diabetes or type 2 diabetes. METHODS: Immunostaining and high-dimensional image analysis were performed on pancreatic sections from a cross-sectional cohort of 54 donors obtained from the Network for Pancreatic Organ Donors with Diabetes (nPOD) repository, to evaluate PC1/3 expression patterns in islet alpha, beta and delta cells at different stages of diabetes. RESULTS: Alpha and beta cell morphology were altered in donors with type 1 diabetes, including decreased alpha and beta cell size. As expected, the insulin-positive and PC1/3-positive areas in the islets were both reduced, and this was accompanied by a reduced percentage of PC1/3-positive and insulin-positive/PC1/3-positive cells in islets. PC1/3 and insulin co-localisation was also reduced. The glucagon-positive area, as well as the percentage of glucagon-positive and glucagon-positive/PC1/3-positive cells in islets, was increased. PC1/3 and glucagon co-localisation was also increased in donors with type 1 diabetes. The somatostatin-positive cell area and somatostatin staining intensity were elevated in islets from donors with recent-onset type 1 diabetes. CONCLUSIONS/INTERPRETATION: Our high-resolution histomorphological analysis of human pancreatic islets from donors with and without diabetes has uncovered details of the cellular origin of islet prohormone peptide processing defects. Reduced beta cell PC1/3 and increased alpha cell PC1/3 in islets from donors with type 1 diabetes pinpointed the functional deterioration of beta cells and the concomitant potential increase in PC1/3 usage for prohormone processing in alpha cells during the pathogenesis of type 1 diabetes. Our finding of PC1/3 loss in beta cells may inform the discovery of new prohormone biomarkers as indicators of beta cell dysfunction, and the finding of elevated PC1/3 expression in alpha cells may encourage the design of therapeutic targets via leveraging alpha cell adaptation in diabetes.
引用
- Apaolaza PS, Chen YC, Grewal K, et al. Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes. Diabetologia. 2024. PMID: 39404844. doi:10.1007/s00125-024-06275-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。